
Global Fluorescence Molecular Imaging Equipment Market Growth 2025-2031
Description
The global Fluorescence Molecular Imaging Equipment market size is predicted to grow from US$ 5074 million in 2025 to US$ 6873 million in 2031; it is expected to grow at a CAGR of 5.2% from 2025 to 2031.
Fluorescence molecular imaging is a type of medical imaging that provides detailed pictures of what is happening inside the body at the molecular and cellular level.
United States market for Fluorescence Molecular Imaging Equipment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Fluorescence Molecular Imaging Equipment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Fluorescence Molecular Imaging Equipment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Fluorescence Molecular Imaging Equipment players cover GE HealthCare, SIEMENS, Koninklijke Philips N.V., Bruker Corporation, Fujifilm Holdings Corp., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Fluorescence Molecular Imaging Equipment Industry Forecast” looks at past sales and reviews total world Fluorescence Molecular Imaging Equipment sales in 2024, providing a comprehensive analysis by region and market sector of projected Fluorescence Molecular Imaging Equipment sales for 2025 through 2031. With Fluorescence Molecular Imaging Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fluorescence Molecular Imaging Equipment industry.
This Insight Report provides a comprehensive analysis of the global Fluorescence Molecular Imaging Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fluorescence Molecular Imaging Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fluorescence Molecular Imaging Equipment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fluorescence Molecular Imaging Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fluorescence Molecular Imaging Equipment.
This report presents a comprehensive overview, market shares, and growth opportunities of Fluorescence Molecular Imaging Equipment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
PET
SPECT
NMR Spectrometer
Others
Segmentation by Application:
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GE HealthCare
SIEMENS
Koninklijke Philips N.V.
Bruker Corporation
Fujifilm Holdings Corp.
Shanghai United Imaging Healthcare Co., LTD
mindray
DPM
Carestream Health
Mirada Medical Limited
Hermes Medical Solutions
Wandong
Neusoft
Key Questions Addressed in this Report
What is the 10-year outlook for the global Fluorescence Molecular Imaging Equipment market?
What factors are driving Fluorescence Molecular Imaging Equipment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fluorescence Molecular Imaging Equipment market opportunities vary by end market size?
How does Fluorescence Molecular Imaging Equipment break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Fluorescence molecular imaging is a type of medical imaging that provides detailed pictures of what is happening inside the body at the molecular and cellular level.
United States market for Fluorescence Molecular Imaging Equipment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Fluorescence Molecular Imaging Equipment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Fluorescence Molecular Imaging Equipment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Fluorescence Molecular Imaging Equipment players cover GE HealthCare, SIEMENS, Koninklijke Philips N.V., Bruker Corporation, Fujifilm Holdings Corp., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Fluorescence Molecular Imaging Equipment Industry Forecast” looks at past sales and reviews total world Fluorescence Molecular Imaging Equipment sales in 2024, providing a comprehensive analysis by region and market sector of projected Fluorescence Molecular Imaging Equipment sales for 2025 through 2031. With Fluorescence Molecular Imaging Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fluorescence Molecular Imaging Equipment industry.
This Insight Report provides a comprehensive analysis of the global Fluorescence Molecular Imaging Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fluorescence Molecular Imaging Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fluorescence Molecular Imaging Equipment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fluorescence Molecular Imaging Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fluorescence Molecular Imaging Equipment.
This report presents a comprehensive overview, market shares, and growth opportunities of Fluorescence Molecular Imaging Equipment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
PET
SPECT
NMR Spectrometer
Others
Segmentation by Application:
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GE HealthCare
SIEMENS
Koninklijke Philips N.V.
Bruker Corporation
Fujifilm Holdings Corp.
Shanghai United Imaging Healthcare Co., LTD
mindray
DPM
Carestream Health
Mirada Medical Limited
Hermes Medical Solutions
Wandong
Neusoft
Key Questions Addressed in this Report
What is the 10-year outlook for the global Fluorescence Molecular Imaging Equipment market?
What factors are driving Fluorescence Molecular Imaging Equipment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fluorescence Molecular Imaging Equipment market opportunities vary by end market size?
How does Fluorescence Molecular Imaging Equipment break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
107 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Fluorescence Molecular Imaging Equipment by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Fluorescence Molecular Imaging Equipment by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.